Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0355589 ANTI-TIGIT ANTIBODIES
The present invention relates to anti-TIGIT antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.
2016/0355588 Bispecific CD3 and CD19 Antigen Binding Constructs
Bispecific antigen binding constructs are described that bind to CD3 and CD19 or CD20 antigens.
2016/0355587 ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHODS OF USE THEREOF
The invention relates generally to antibodies that bind CD166, activatable antibodies that specifically bind to CD166 and methods of making and using these...
2016/0355586 Covalent Diabodies and Uses Thereof
The present invention is directed to diabody molecules and uses thereof in the treatment of a variety of diseases and disorders, including immunological...
2016/0355585 ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP
The present invention is directed to therapeutic methods using IL-6 antagonists such as antibodies and fragments thereof having binding specificity for IL-6 to...
2016/0355584 ANTIBODIES NEUTRALIZING GM-CSF FOR USE IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR AS ANALGESICS
The invention relates to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of inflammatory disorders such as...
2016/0355583 ANTIBODIES TARGETING BONE MORPHOGENETIC PROTEIN 9 (BMP9) AND METHODS THEREFOR
The present invention relates to isolated antibodies and antigen-binding fragments thereof which bind human BMP9 and compositions and methods of use thereof.
2016/0355582 VHH FOR APPLICATION IN TISSUE REPAIR, ORGAN REGENERATION, ORGAN REPLACEMENT AND TISSUE ENGINEERING
The present invention relates to a VHH which binds to a growth factor or is an antagonist for a growth factor, or binds to an implant.
2016/0355581 COMPOSITIONS AND METHODS FOR TREATING AMYLOID PLAQUE ASSOCIATED SYMPTOMS
The present invention encompasses compositions and methods for effectively treating at least one symptom or sign of A.beta. plaque associated symptoms or for...
2016/0355580 METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS
The present disclosure relates to, inter alia, compositions containing an inhibitor of human complement and use of the compositions in methods for treating or...
2016/0355579 METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS
The present disclosure relates to, inter alia, compositions containing an inhibitor of human complement and use of the compositions in methods for treating or...
2016/0355578 METHODS OF TREATING A TAUOPATHY
The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau...
2016/0355577 METHODS AND COMPOSITIONS FOR TARGETING POLYUBIQUITIN
Anti-K63-linked polyubiquitin monoclonal antibodies, and methods for using the antibodies, are provided.
2016/0355576 ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR
Provided are novel human-derived antibodies specific for transthyretin (TTR), preferably capable of binding misfolded, misassembled, and/or aggregated TTR...
2016/0355575 OLIGOPEPTIDE AND METHODS FOR PRODUCING CONJUGATES THEREOF
The present invention relates to an oligopeptide and conjugates thereof. The present invention also relates to the use of these oligopeptide conjugates for...
2016/0355574 HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
The present disclosure is directed to humanized anti-C1q antibodies and methods of using them.
2016/0355573 GENE THERAPY FOR ALZHEIMER'S AND OTHER NEURODEGENERATIVE DISEASES AND CONDITIONS
Gene therapy compositions and methods to inhibit or treat neurodegenerative diseases, e.g., Alzheimer's disease, are provided.
2016/0355572 SYSTEM, APPARATUS AND METHOD FOR BIOMOLECULES PRODUCTION
An automated method for the production of cells and/or biomolecules such as protein or peptides includes culturing cells in at least one high cell density...
2016/0355571 LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR1, CDR2, AND CDR3 AND NOVEL LC CDR1, CDR2, AND CDR3 DESIGNS
Provided are compositions and methods for preparing and identifying antibodies having CDR3s that vary in sequence and in length from very short to very long...
2016/0355570 IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS
IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are...
2016/0355569 SURFACE, ANCHORED FC-BAIT ANTIBODY DISPLAY SYSTEM
The present invention provides, in part, an antibody display system that simultaneously uses a secretion and a display mode. A bait complexed with a monovalent...
2016/0355568 RECOMBINANT FACTOR VIII PROTEINS
Provided are recombinant Factor VIII proteins, e.g., human Factor VIII proteins with heterologous moieties inserted into flexible permissive loops located in...
2016/0355567 MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME
The invention provides soluble fusion protein complexes having at least two soluble fusion proteins. The first fusion protein is a biologically active...
2016/0355566 Novel Synthetic Biology-Based ADCC Technology
A novel synthetic biology-based ADCC technology is provided that enhances or enables ADCC response. The novel ADCC technology can be used to prevent or treat...
2016/0355565 DIAGNOSIS OF A NEUROAUTOIMMUNE DISEASE
A method for diagnosing a disease by detecting an autoantibody that binds to flotillin1 and/or flotillin2 in a sample, a polypeptide comprising flotillin1...
2016/0355564 METHOD TO DETECT AUTOANTIBODY REACTIVITY FOR DEAMIDATED INSULIN AUTOANTIGEN IN DIABETES
Provided herein are epitopes and mimotopes thereof useful in the diagnosis and treatment of type 1 diabetes (T1D), as well as antibodies recognizing such...
2016/0355563 GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
GLP-2 analogues are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1...
2016/0355562 STABLE, PROTRACTED GLP-1/GLUCAGON RECEPTOR CO-AGONISTS FOR MEDICAL USE
The invention relates to novel stable and protracted GLP-1/glucagon receptor co-agonists, to the use of said peptides in therapy, to methods of treatment...
2016/0355561 Cell penetrating protein adaptor molecules and their application in research and medicine
Coupling proteins that make strong protein-protein interactions equipped with cell penetrating peptides (CPPs) provide a convenient and powerful method to...
2016/0355560 NETRIN-1 AND DEPENDENCE RECEPTOR PROTEINS AND METHODS OF USE
Provided herein are fragments of Netrin-1 proteins, fragments of DCC proteins and NEO1 proteins, and antibodies to epitopes located within the fragments of...
2016/0355559 NORRIN REGULATION OF CELLULAR PRODUCTION OF JUNCTION PROTEINS AND USE TO TREAT RETINAL VASCULATURE EDEMA
A method of tightening inter-cellular junctions in retinal or choroidal vessel cells includes exposing the retinal or choroidal vessel cells to norrin. Upon...
2016/0355558 Methods for Treatment of Nephrotic Syndrome and Related Conditions
The present disclosure provides a polypeptide and method for treating and/or preventing nephrotic syndrome, such as but not limited to those associated with...
2016/0355557 SAXATILIN-FC FUSION PROTEIN AND USE THEREOF
The present invention relates to a saxatilin derivative having an increased half life and a use thereof. The saxatilin derivative of the present invention has...
2016/0355556 NOVEL NEUROPEPTIDES USEFUL AS INSECTICIDES
The invention provides short peptides derived from an insect neuropeptide for controlling insects, particularly peptides or their analogs derived from PBAN...
2016/0355555 MIMOTOPES FOR USE IN IMMUNOTHERAPY FOR SHELLFISH AND/OR ARTHROPOD ALLERGY
The present invention provides isolated peptides and nucleic acids encoding the isolated peptides that can modify a subject's immune response to tropomyosin....
2016/0355554 Fusobacterium polypeptides and methods of use
The present invention provides isolated polypeptides isolatable from a Fusobacterium spp. Also provided by the present invention are compositions that include...
2016/0355553 INFLUENZA VIRUS VACCINES AND USES THEREOF
The present disclosure provides influenza hemagglutinin stem domain polypeptides comprising (a) an influenza hemagglutinin HA1 domain that comprises an HA1...
2016/0355552 METHODS AND COMPOSITIONS FOR RIBOSOMAL SYNTHESIS OF MACROCYCLIC PEPTIDES
Methods and compositions are provided for generating macrocyclic peptides from genetically encoded, ribosomally produced polypeptide precursors. Also provided...
2016/0355551 USE OF TIGHT JUNCTION ANTAGONISTS IN THE TREATMENT OF ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS
The present application provides compositions and methods for treating acute lung injury and acute respiratory distress syndrome. The methods include...
2016/0355550 NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the...
2016/0355549 PEPTIDE HAVING ACTIVITY OF INHIBITING PRODUCTION OF TOXIN BY BACTERIUM BELONGING TO GENUS CLOSTRIDIUM
To provide a means for preventing, treating and/or controlling health damages, including food poisoning and infections, caused by a bacterium belonging to the...
2016/0355548 TUMOR-TARGETING POLYPEPTIDE AND APPLICATION THEREOF
This invention provides a tumor-targeting peptide. This tumor-targeting peptide comprises a typical motif with the general formula of: XX(Y/F) (D/E) (D/E) XX....
2016/0355547 Dimeric IAP Inhibitors
Molecular mimics of Smac are capable of modulating apoptosis through their interaction with cellular IAPs (inhibitor of apoptosis proteins). The mimetics are...
2016/0355546 METHODS AND SYSTEMS FOR RECOVERING PROTEIN POWDER AND NATURAL OMEGA-3 OIL FROM ANIMAL TISSUE
Provided are methods and systems for recovering protein product powder, purified water and omega-3 oil from an animal tissue. The methods and systems use high...
2016/0355545 METHOD FOR IMPROVING PROTEIN FUNCTIONALITY USING VORTEXING FLUID SHEAR FOCES
A method of improving protein functionality includes obtaining a protein such as protein contained within exclusion bodies contained within bacteria or yeast...
2016/0355544 NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3BETA-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC...
5-cholesten, 3.beta., 25-diol, disulfate (25HCDS) has been found to be an authentic PPAR.sub..gamma. agonist and LXR antagonist, and is used for the therapy of...
2016/0355543 SALTS OF HIV INHIBITOR COMPOUNDS
The invention is related to salts of anti-viral compounds, compositions containing such salts, and therapeutic methods that include the administration of such...
2016/0355542 UNIVERSAL METHYLATION PROFILING METHODS
The present invention provides a method of determining whether cytosine residues present at a predetermined positions within a single strand of a double...
2016/0355541 DISULFIDE-LINKED REVERSIBLE TERMINATORS
The present disclosure provides methods of sequencing polynucleotides and compounds, compositions useful for sequencing of polynucleotides. The chemical...
2016/0355540 5-POSITION MODIFIED PYRIMIDINES AND THEIR USE
The present disclosure relates to the field of nucleic acid chemistry, specifically to 5-position modified uridines as well as phosphoramidite and triphosphate...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.